Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06896474 · ClinicalTrials.gov registry record · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
A NA study of Breast Cancer, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 402
- Enrollment target
- 11
- Study locations
NCT06896474 is a NA study of Breast Cancer that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 402 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 11 study locations across 6 states.
The verdict
NCT06896474, a NA study of Breast Cancer, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
- 11
- Study locations
Study Summary
Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, a shared decision making training for surgeons plus patient decision aid vs. usual care (UC), at 7 large health systems across the U.S. to learn the intervention's effectiveness. Decision aids will be mailed and sent via patient portal and/or via email (when portal/email addresses are available) to patients before their first surgical encounter. The central hypothesis is that the novel intervention will be a key resource to support shared decision making leading to higher quality treatment decisions and as result improved care and outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Shared Decision-Making Training and Decision Aid
Study Locations (11)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Brigham and Women's Hospital - Boston
- Dana Farber Cancer Institute - Boston
- Lahey Hospital and Medical Center - Burlington
- Beth Israel Deaconess Hospital - Needham
- Dana-Farber/Brigham and Women's Cancer Center at South Shore Hospital - Weymouth
California
- Beckman Research Institute of the City of Hope - Los Angeles
New Jersey
- Rutgers State University of New Jersey Medical School - Newark
New Mexico
- University of New Mexico - Albuquerque
New York
- University of Rochester - Rochester
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2026-02-04 |
| Est. Completion | 2033-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06896474
The ClinicalTrials.gov registry entry for NCT06896474 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 402 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Shared Decision-Making Training and Decision Aid is the first listed.
NCT06896474 reports 11 study locations spanning 6 distinct geographic areas - top geographies include Massachusetts, California, New Jersey.
Frequently Asked Questions
What is clinical trial NCT06896474 about?
NCT06896474 is a clinical study titled "SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers". Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, a shared decision making training for surgeons plus patient decision aid vs. usual care (UC), at 7 large health systems across the U.S. to le...
What is the current status of trial NCT06896474?
This trial is currently recruiting. It is a NA study. The enrollment target is 402 participants. The study started on 2026-02-04. Estimated completion is 2033-09-30.
What conditions does trial NCT06896474 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT06896474?
The interventions under investigation include: Shared Decision-Making Training and Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT06896474?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06896474 being conducted?
This trial has 11 study locations across California, Massachusetts, New Jersey, New Mexico, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.